News from Atom Bioscience
PRESS RELEASE Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic...
PRESS RELEASE Atom Bioscience Announces Abstract for Its Phase 2a Gout Study Accepted for American College...
PRESS RELEASE Atom Bioscience to Update Clinical Development of New Drug to Treat Gout at BIO International...
PRESS RELEASE On Gout Awareness Day, Let’s Put the Myths to Rest Genetic abnormalities are the real cause...
PRESS RELEASE Atom Bioscience Announces Positive Phase 2a Results For Investigational New Drug to Treat...
Lead drug targets unmet medical need in chronic gout Provides significant serum uric acid reduction in...
Lead drug targets unmet medical need in chronic gout Provides significant efficacy without toxic side...
Atom Bioscience Raises $47 Million in Series C Round of Financing to Advance Development of Small Molecule...
Atom Bioscience is a biopharmaceutical company focusing on the research and development of metabolic...
Atom Bioscience’s innovative gout drug has passed the IND application in the United States and...
Industry News
Arthritis & Rheumatology: Study Compares Gout Treatments with Different Mechanisms of Action –...